(Reuters) – U.S. mobile app and gaming company AppLovin Corp sold shares in its initial public offering (IPO) at the
Opinion | We Need an Infrastructure Package for Nature
We were driving through Long Island’s sprawling road system in a borrowed electric car when we heard the news about
European stocks slip from record highs as focus shifts to earnings
(Reuters) -European stocks fell on Monday from all-time highs as investors booked profits ahead of the quarterly corporate earnings season,
Opinion | Every Pandemic Death Leaves Behind a Circle of Grief
The end of the Covid-19 crisis in the United States is in sight, thanks to effective vaccines being deployed on
Billionaire Paulsen's PolyPeptide Group plans Swiss IPO to fund growth
ZURICH (Reuters) – PolyPeptide Group, controlled by a foundation of Swedish billionaire adventurer Frederik Paulsen Jr., said Monday it plans
Opinion | Medical School Needs a Dose of the Humanities
Over the past year, ordinary medical research nearly ground to a halt as researchers focused on coronavirus vaccine trials and
Biotech firm Ginkgo in talks with Harry Sloan-led SPAC for over $20 billion deal
(Reuters) – Biotech startup Ginkgo Bioworks is in talks to go public through a merger with a blank-check firm backed
Opinion | Racism Makes Me Question Everything. I Got the Vaccine Anyway.
Surviving in an anti-Black society requires some personal negotiations. This was one of them. By Damon Young Mr. Young is
Opinion | Did the Boomers Ruin America? A Debate.
Produced by ‘The Ezra Klein Show’ Donald Trump was the fourth member of the baby boomer generation to be elected
Three Million Daily Shots, Achieved
Shortly after President Biden took office, I began asking his aides why their publicly announced goal for Covid-19 vaccine distribution